IGKV1D-22 and plasma cell myeloma: Interestingly, S100 genes have been found to confer resistance to proteasome inhibitors, of which the members S100A8 and A9 were among the genes with the greatest increase in expression in relapse versus diagnosis LCE-multiple myeloma (23).